ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB
Improving cancer immunotherapy efficacy hinges on identifying key T-cell populations critical for tumor control and response to Immune Checkpoint Blockade (ICB). We have recently reported that while the co-expression of PD-1 and CD28 is associated with impaired functionality in peripheral blood, it...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Taylor & Francis Group
2024-12-01
|
| 叢編: | OncoImmunology |
| 主題: | |
| 在線閱讀: | https://www.tandfonline.com/doi/10.1080/2162402X.2024.2371051 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|